Simon Kung, M.D.

A discussion on TMS indications, patient selection, treatment protocols, efficacy, side effects, and comparisons with ECT. Dr. Kung also explains newer TMS approaches like intermittent theta burst stimulation and the SAINT protocol, as well as potential future developments in the field.

In this presentation, Dr. Simon Kung immerses us in the world of TMS. He reviews the basis of TMS, the FDA-approved devices and coils, and its potential side effects. Dr. Kung also reviews the evidence supporting the application of TMS in the treatment of depression, obsessive-compulsive disorder, and smoking cessation. To conclude his presentation, he provides insight into insurance companies' criteria for TMS coverage and presents a clinical case study. This effectively illustrates the patient's response to TMS treatment, their sustained improvement, the prescribed treatment regimen followed, and a plan designed to address possible relapse scenarios.

In this interview, Dr. Simon Kung discusses pharmacogenetic testing in psychiatry. He aims to guide clinicians on to how to better incorporate this knowledge into clinical practice.

Dr. Simon Kung discusses the use of repetitive transcranial magnetic stimulation in the treatment of psychiatric disorders. Dr. Kung describes patients who benefit the most from TMS; other variants of TMS, like deep TMS; and the novel intermittent theta-burst stimulation, as well as the future of TMS.

In this presentation, Dr. Simon Kung demonstrates the basics and implications of pharmacogenomics in the treatment of common psychiatric conditions. The pharmacogenomic profiles of the most significant cytochrome P450 enzymes are covered as well as a review of the evidence that backs this new approach.

This presentation by Dr. Simon Kung covers the basics of repetitive transcranial magnetic stimulation and its efficacy and safety for a diverse range of psychiatric conditions. You will also learn about TMS for the treatment of OCD.